Blog

Will BioNTech Be a Trillion-Dollar Company by 2023?

BioNTech (NASDAQ: BNTX) is a popular coronavirus stock with a return of 805.7% since the beginning of the pandemic in January 2020. With that pace of growth, many investors are already wondering if

TheMotleyFool

0

Moderna Is Up 500% in 12 Months. Can It Keep Going?

Biotechnology company Moderna (NASDAQ: MRNA) came to market in 2018 with a market cap of about $7.5 billion. Today, the company is worth more than $150 billion. With its work as a leader in

TheMotleyFool

0

News Flash: YouTube's About to Leave Netflix in the Dust

YouTube has always had more viewers than Netflix (NASDAQ: NFLX), but now the ad-supported streaming service is set to generate more revenue than the leading subscription video on demand platform

TheMotleyFool

0

Did Pfizer's and BioNTech's FDA Submission Boost the Case for Booster Doses for All Americans?

Third booster doses are on the way for Americans who have received messenger RNA (mRNA) COVID-19 vaccines. The Food and Drug Administration and the Centers for Disease Control & Prevention made the

TheMotleyFool

0

This Pure-Play Insurer Could Help You Outperform the Market

Virginia-based Kinsale Capital (NASDAQ: KNSL) operates entirely within the excess and surplus (E&S) insurance industry, a property and casualty market segment. Excess and surplus insurance is a

TheMotleyFool

0

3 Dow Stocks Billionaire Money Managers Couldn't Stop Buying in the Second Quarter

In case you missed it, one of the most important data releases of the third quarter happened last week. Aug. 16 marked the deadline for institutional firms and hedge funds with at least $100 million

TheMotleyFool

0

3 Things About BioNTech That Smart Investors Know

Since the early days of the pandemic, a group of biotech companies have seen their stocks tied tightly to the prospects of a COVID-19 vaccine. The potential windfall from a successful drug simply

TheMotleyFool

0

3 Pharma Stocks to Buy With Juicy Dividends

There are several industries and sectors that are known for their dividends. Utilities and real estate investment trusts definitely come to mind. But so does the pharmaceutical industry. Big pharma

TheMotleyFool

0

4 Growth Stocks With 116% to 247% Upside, According to Wall Street

Patience has paid off handsomely for investors in 2021. It's been over nine months since the benchmark S&P 500 underwent even a 5% correction. Panning out a bit further, the widely followed index

TheMotleyFool

0

Better Biotech Stock: Cassava Sciences vs. Annovis Bio

Investing in pre-product biotech companies often feels like gambling. Financial analysis might not deliver meaningful conclusions for businesses without revenue, and the risks inherent to the drug

TheMotleyFool

0

How Much Will I Get From Social Security if I Make $100,000?

Asking how much you will get from Social Security is a question well worth asking in light of how much our paychecks shrink thanks to Federal Insurance Contributions Act (FICA) deductions. Will we

TheMotleyFool

0

Here's What Gen Xers Have Saved for Retirement. How Do You Compare?

Social Security could end up being an important source of income for you in retirement. But can you retire on those benefits alone? Probably not.

Social Security will generally replace about 40% of

TheMotleyFool

0

Lannett Company, inc (LCI) Q4 2021 Earnings Call Transcript

Image source: The Motley Fool.

Lannett Company, inc (NYSE: LCI)Q4 2021 Earnings CallAug 25, 2021, 4:30 p.m. ET

Operator

Source Fool.com

TheMotleyFool

0

3 Social Security Moves to Make if You're Married

Social Security benefits can be a lifeline in retirement, especially if your savings are falling short. But it's important to make sure you're taking full advantage of your monthly checks and

TheMotleyFool

0